Healthcare Jan 23, 2022 05:59 PM (GMT+8) · EqualOcean
Kangtai biology announced that Beijing minhai Biotechnology Co., Ltd. (hereinafter referred to as "minhai biology"), a wholly-owned subsidiary of the company, recently received the notice of the drug review center on initiating the on-site verification of the registration of freeze-dried human rabies vaccine (human diploid cells) issued by the drug review center of the state food and Drug Administration (hereinafter referred to as "drug review center"). According to the relevant provisions of the measures for the administration of drug registration, The drug approval center shall start the drug registration verification (Pharmacy) for the freeze-dried human rabies vaccine (human diploid cells) (acceptance No.: cxss2101046) declared and registered by minhai biology.

This text is a result of machine translation.

Related companies：